Home › Funds › BVF INC/IL › RVMD

BVF INC/IL position in RVMD

REVOLUTION MEDICINES INC · Health Care

BVF INC/IL reported holding 2,965,160 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$555.3M, representing 14.20% of its reported portfolio and ranking #1 among its reported holdings. BVF INC/IL has disclosed RVMD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.97M sh
Reported value held$555.32M
Portfolio Weight14.20%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's RVMD position evolved

BVF INC/IL first disclosed a stake in RVMD in Q3 2023 at 3,981,212 shares (US$110.2M). The position peaked in Q2 2026 at 2,965,160 shares, worth US$555.3M. Across 12 filings, BVF INC/IL increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 2,965,160 shares valued at US$555.3M — an increase of 108,378 shares quarter over quarter.. Notable position changes include a 50% increase in Q4 2023 (shares rose 12% over the following quarter), a 42% trim in Q3 2024 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.98M $110.20M New
Q4 2023 5.98M $171.54M Add
Q1 2024 5.98M $192.77M Hold
Q2 2024 5.98M $232.13M Hold
Q3 2024 3.48M $157.76M Reduce
Q4 2024 4.18M $182.88M Add
Q1 2025 4.98M $176.18M Add
Q2 2025 4.98M $183.30M Hold
Q3 2025 3.97M $185.63M Reduce
Q4 2025 3.36M $267.37M Reduce
Q1 2026 2.86M $277.82M Reduce
Q2 2026 2.97M $555.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 60 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has BVF INC/IL held RVMD?

BVF INC/IL has disclosed RVMD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BVF INC/IL's current position in RVMD?

As of Q2 2026, BVF INC/IL holds 2.97M shares of RVMD (REVOLUTION MEDICINES INC), valued at $555.32M, representing 14.20% of its reported portfolio and ranking #1.

Has BVF INC/IL been buying or selling RVMD?

In the latest 13F filing (Q2 2026), BVF INC/IL increased its position in RVMD. The position peaked in Q2 2026 at 2.97M shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.